American Journal of Health-System Pharmacy, Vol. 63, Issue 19,
1828-1835
Copyright © 2006 by American Society of Health-System Pharmacists
Treatment of poisoning caused by ß-adrenergic and calcium-channel blockers
Greene Shepherd
GREENE SHEPHERD, PHARM.D., DABAT, is Clinical Associate Professor, Medical College of Georgia, 1120 15th Street, CJ-1020, Augusta, GA 30912-2450 (jshepherd{at}mcg.edu).
|
Purpose. The toxic effects and treatment of ß-adrenergic blocker and calcium-channel blocker (CCB) overdose are reviewed.
Summary. Overdoses with cardiovascular drugs are associated with significant morbidity and mortality. Beta-blockers and CCBs represent the most important classes of cardiovascular drugs. In overdose, ß-blockers and CCBs have similar presentation and treatment overlaps and are often refractory to standard resuscitation measures. The common feature of ß-blocker toxicity is excessive blockade of the ß-receptors resulting in bradycardia and hypotension. Poisoning by CCBs is characterized by cardiovascular toxicity with hypotension and conduction disturbances, including sinus bradycardia and varying degrees of atrioventricular block. Therapies include ß-agonists, glucagon, and phosphodiesterase inhibitors. However, in ß-blocker poisoning where symptomatic bradycardia and hypotension are present, high-dose glucagon is considered the first-line antidote. Traditionally, antidotes for CCB overdose have included calcium, glucagon, adrenergic drugs, and amrinone. For cases of CCB poisoning where cardiotoxicity is evident, first-line therapy is a combination of calcium and epinephrine; high-dose insulin with supplemental dextrose and potassium therapy (HDIDK) is reserved for refractory cases. Health-system pharmacists should be aware that when these drugs are used as antidotes, higher than normal dosing is needed.
Conclusion. Poisoning by ß-blockers or CCBs usually produces hypotension and bradycardia, which may be refractory to standard resuscitation measures. For cases of ß-blocker poisoning where symptomatic bradycardia and hypotension are present, high-dose glucagon is considered the first-line antidote. For cases of CCB poisoning where cardiotoxicity is evident, a combination of calcium and epinephrine should be used initially, reserving HDIDK for refractory cases.
Index terms: Amrinone; Antidotes; Calcium; Calcium antagonists; Combined therapy; Dextrose; Dosage; Epinephrine; Glucagon; Insulin; Phosphodiesterase inhibitors; Poisoning; Potassium; Sympatholytic agents; Sympathomimetic agents; Toxicity
|
This article has been cited by other articles:

|
 |

|
 |
 
T. Varpula, J. Rapola, M. Sallisalmi, and J. Kurola
Treatment of Serious Calcium Channel Blocker Overdose With Levosimendan, a Calcium Sensitizer
Anesth. Analg.,
March 1, 2009;
108(3):
790 - 792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kaplan, N Hocaoglu, K Oransay, S Kalkan, and Y Tuncok
Effect of glucagon on amitriptyline-induced cardiovascular toxicity in rats
Human and Experimental Toxicology,
April 1, 2008;
27(4):
321 - 325.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Alapat and J. L. Zimmerman
Toxicology in the Critical Care Unit
Chest,
April 1, 2008;
133(4):
1006 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society of Health-System Pharmacists.
|
|